XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:      
Cash and cash equivalents $ 7,179 $ 387,391 $ 1,123,843
Short-term investments 89,576 99,715  
Accounts receivable, net 317,619 301,775  
Prepaid expenses 16,323 18,538  
Income taxes receivable 0 14,249  
Other current assets 9,080 18,896  
Total current assets 439,777 840,564  
Property and equipment, net 72,458 70,154  
Goodwill 1,528,694 1,505,430  
Intangible assets, net 21,050 21,565  
Operating and finance lease right-of-use assets 66,055 65,461  
Deferred income tax assets 84,741 88,344  
Other assets 128,201 131,028  
Total assets 2,340,976 2,722,546  
Current liabilities:      
Accounts payable and accrued expenses 232,089 394,118  
Current portion of finance lease liabilities 2,404 2,490  
Current portion of operating lease liabilities 20,885 19,684  
Income taxes payable 14,349 11,074  
Total current liabilities 269,727 427,366  
Line of credit 149,000 0  
Long-term debt and finance lease liabilities, net 655,930 1,002,258  
Long-term operating lease liabilities 40,989 41,396  
Long-term professional liabilities 265,082 271,093  
Deferred income tax liabilities 39,301 41,409  
Other liabilities 43,871 42,332  
Total liabilities 1,463,900 1,825,854  
Commitments and contingencies
Shareholders' equity:      
Preferred stock; $.01 par value; 1,000 shares authorized; none issued 0 0  
Common stock; $.01 par value; 200,000 shares authorized; 87,184 and 86,423 shares issued and outstanding, respectively 872 864  
Additional paid-in capital 1,054,141 1,049,696  
Accumulated other comprehensive income (1,351) 1,317  
Retained deficit (176,586) (155,390)  
Total Mednax, Inc. shareholders' equity 877,076 896,487  
Noncontrolling interest 0 205  
Total equity 877,076 896,692 $ 747,717
Total liabilities and equity $ 2,340,976 $ 2,722,546